Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: Results from a validation study Biostatistics and methods

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Ohlmeier, Christoph ^a   Langner, Ingo ^a   Hillebrand, Kathrin ^b   Schmedt, Niklas ^a   Mikolajczyk, Rafael ^c,d   Riedel, Oliver ^a   Garbe, Edeltraut ^a,e  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF BREMEN   (Germany)

Author keywords

Administrative data; Claims data; Death; Germany; Health insurance data; Mortality; Validation

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CELL REPROGRAMMING TECHNIQUE; CHILD; EPIDEMIOLOGY; FACTUAL DATABASE; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMAN; INFANT; INSURANCE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NEWBORN; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; PROCEDURES; SEX RATIO; SOCIOECONOMICS; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CELLULAR REPROGRAMMING TECHNIQUES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; MORTALITY; PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84934962335     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1943-7     Document Type: Article

References (12)

1. Schubert I, Köster I, Küpper-Nybelen J, Ihle P. Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008;51(10):1095-105.
2. Hoffmann F, Andersohn F, Giersiepen K, Scharnetzky E, Garbe E. Validation of secondary data. Strengths and limitations. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008;51(10):1118-26.
3. Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011;64(8):821-9.
4. Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf. 2008;17(3):215-23.
5. Garbe E, Suling M, Kloss S, Lindemann C, Schmid U. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf. 2011;20(3):258-64.
6. Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen. 2012;74(5):291-7.
7. Statistisches Bundesamt. Todesursachen in Deutschland. Gestorbene in Deutschland an ausgewählten Todesursachen. Wiesbaden: Fachserie 12 Reihe 4; 2007
8. Daly LE. Confidence limits made easy. interval estimation using a substitution method. Am J Epidemiol. 1998;147(8):783-90.
9. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16(7):791-801.
10. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998;279(21):1703-8.
11. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, Kunst AE. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468-81.
12. Hoffmann F, Icks A. Do persons that changed health insurance differ from those who did not? The case of diabetes. Exp Clin Endocrinol Diabetes. 2011;119(9):569-72.